Ranbaxy pushes court to dismiss Meijer's antitrust case
MLex Summary: Ranbaxy Laboratories and Sun Pharmaceutical filed a reply in support of their motion to dismiss claims that they conspired to delay the market entry of several generic drugs. The drugmakers...To view the full article, register now.
Already a subscriber? Click here to view full article